Physician profile
Christian Tharale Morrison
NPI 1487159570
$5,994.49
in general payments reported to CMS, 2019-2025
13 companies · $785 in 2025
The $785 reported for 2025 was more than what 83% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $455 · 2022: $610 · 2023: $3,108 · 2024: $1,037 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,333 · Travel and Lodging: $1,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,332.56 |
| Travel and Lodging | $1,596.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,565.25 | 2021-2025 | Augment Injectable, Hoffmann, Gamma |
| Smith+Nephew, INC. | $1,115.89 | 2022-2025 | Grafix Pl, Stravix Pl, Stravix |
| Abbott Laboratories | $213.35 | 2024-2025 | Ensite, Diamondback Peripheral |
| Paragon 28, INC. | $193.33 | 2021 | |
| Averitas Pharma INC. | $165.10 | 2025 | Qutenza |
| Biotissue Holdings INC. | $163.39 | 2023 | |
| Paratek Pharmaceuticals, INC. | $138.34 | 2023-2025 | Nuzyra |
| Polynovo North America LLC | $128.66 | 2025 | Novosorb Btm |
| Cardiovascular Systems INC. | $94.80 | 2022-2023 | Diamondback Peripheral |
| Integra Lifesciences Corporation | $90.63 | 2024 | Medihoney, Biodfactor, Biodrestore |
| Medtronic, INC. | $89.49 | 2021 | |
| Axogen | $24.10 | 2025 | |
| Pylant Medical | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.